Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. uri icon

authors

  • Burns, Daniel K
  • Burke, James R
  • Wu, Jingtao
  • Lutz, Michael W
  • Haneline, Stephen
  • Schwarz, Adam J
  • Schneider, Lon S
  • Kristine Yaffe, MD
  • Saunders, Ann M
  • Ratti, Emiliangelo
  • Alexander, Robert C
  • Welsh-Bohmer, Kathleen A
  • Culp, Meredith
  • Chiang, Carl
  • O'Neil, Janet
  • Evans, Rebecca M
  • Harrigan, Patrick
  • Plassman, Brenda L

publication date

  • January 2021